Researchers issue urgent warning over spread of dangerous disease carried by snails: 'Leading to outbreaks in new locations'
Harmful parasites carried by snails may be spreading, in part due to human-caused climate change, according to reporting from The Telegraph in May. Marginalized populations, including women and girls, may suffer disproportionately from increased prevalence.
Schistosomiasis is a parasitic infection caused by snail-carried worms. Infection typically starts with making contact with the worms in freshwater, such as in a canal, river, or pond. Person-to-person transmission can continue when urine or feces containing the parasite's eggs contaminates a water source.
Symptoms — including fever, chills, coughing, and aches — can manifest within a couple of months, per the Centers for Disease Control and Prevention. Chronic infections can lead to anemia, bloody stools, urinary problems, organ damage, and more.
Historically, 90% of the schistosomiasis cases requiring treatment have been located in Africa, but infections have also been documented in Asia, the Americas, and the Middle East. While the London-based outlet has reported more recent spreading in parts of Europe may be largely tourism- and migration-driven, researcher Bonnie Webster also told the publication that transmissions may emerge in further locations due to shifting weather patterns. Rising global temperatures are driving more frequent and more intense flooding events, causing snails to appear in new wet settings and increasing water contamination.
"Climate change will likely cause dramatic changes in transmission which need to be understood," Webster, who studies the disease at London's Natural History Museum, told The Telegraph. "Some areas will become drier and other areas will become flooded, creating new water bodies. This will lead to snails changing where they can be found and cause the prevalence of schistosomiasis to increase and spread, leading to outbreaks in new locations."
Communities in low- and middle-income countries lacking sufficient sanitation infrastructure are already disproportionately impacted by this serious issue, and women and girls are additionally vulnerable to its effects.
All people can become infected by these parasites, but one manifestation of the disease — female genital schistosomiasis, or FGS — can cause sexual, reproductive, and other health concerns for women and girls. Gendered labor dynamics can make this group additionally susceptible to infection through activities like washing laundry in contaminated water.
Unlimit Health says that around 56 million women and girls in sub-Saharan Africa are infected with FGS, which can go undiagnosed and, especially when misdiagnosed as a sexually transmitted infection or otherwise left untreated, can lead to bleeding, pelvic pain, ulcers, miscarriage, and infertility. It may also contribute to increased risks of HIV and cervical cancer.
Overall, schistosomiasis impacts hundreds of millions of people each year, resulting in up to 20,000 deaths annually, according to The Telegraph.
Unfortunately, as Webster said, "Once one snail is infected, they can infect a whole population of humans."
Do you worry about getting diseases from bug bites?
Absolutely
Only when I'm camping or hiking
Not really
Never
Click your choice to see results and speak your mind.
While treatments exist, potential drug resistance and current medical shortages could hamper attempts to curtail infections. Experts relayed to The Telegraph that recent substantial cuts to the United States Agency for International Development may also stymie research and response efforts for neglected tropical diseases like schistosomiasis.
NTDs disproportionately impact marginalized populations. The World Health Organization says they affect over 1 billion people globally and that NTDs are "often related to environmental conditions." Of course, because of travel and climate change, many such infections may spread to more communities and farther regions.
The CDC notes that prevention includes clean-up of contaminated areas, implementation of sanitation systems, and avoiding swimming, wading, and washing in unsafe water. A number of these measures require funding.
Staying updated about how human-caused climate change can impact health and well-being everywhere can be key to organizing effective responses to rising global temperatures. Especially together in groups, friends and neighbors can make a difference by exploring these issues, raising awareness, supporting pro-environment policies, and taking on climate-conscious shifts at home to help address the extreme weather that imperils billions worldwide.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
CVS responds to Gov. Sanders' New York Times Op-Ed about PBMs
FAYETTEVILLE, Ark. (KNWA/KFTA) — CVS Health is ramping up its campaign against a new Arkansas law that targets pharmacy benefit managers, publicly clashing with Gov. Sarah Huckabee Sanders just hours after she defended the legislation in a guest essay for The New York Times. Act 624, signed by Sanders in April, bars companies from running both a pharmacy and a pharmacy benefit manager (PBM), a model used by CVS. PBMs manage prescription drug benefits for insurers, negotiate prices with drug manufacturers and reimburse pharmacies. In her guest essay on June 10, Sanders wrote that PBMs 'forcibly steer patients away from independent operators' and inflate drug prices. She also wrote that Act 624 lets PBMs keep operating in Arkansas, but, she said, 'they just can't continue to mistreat patients and box out other pharmacies.' Sanders claimed the three largest pharmacy benefit managers handle 80% of U.S. prescriptions and earn 70% of specialty drug revenue through their affiliated pharmacies. 'Now, CVS is threatening to close down every pharmacy it operates in our state — preferring to take its ball and go home rather than divest from its pharmacy benefit management business and actually serve the patients it claims to care about,' Sanders wrote. CVS sues Arkansas over new pharmacy law CVS issued a statement later that day disputing Sanders' characterization of the law, claiming that the new law is about 'choosing winners and losers and rewarding special interests.' 'Out-of-state competitors are disadvantaged,' a CVS spokesperson said. 'In-state competitors, including Walmart, would handsomely benefit from the closures of pharmacies owned by us and others. The losers are the people of Arkansas who will pay more.' CVS says the law could force it to close 23 pharmacies in Arkansas, affecting 340,000 patients, and block its specialty pharmacy from treating 10,000 high-risk patients with cancer, HIV and rare diseases. The company is also challenging Act 624 in federal court, arguing it violates the U.S. Constitution. 'PBMs are the last line of defense between drugmakers that want to charge a lot of money, and the American businesses, unions, health plans, and government agencies that want to provide good benefits to people,' CVS said in its response on June 10. CVS argues the law is unconstitutional because it unfairly targets out-of-state businesses, treats similar companies differently, and conflicts with federal laws like ERISA and Medicare rules. The company also raised concerns about potential conflicts of interest. 'One state representative who co-sponsored this law owns 13 pharmacies by himself,' the company said, linking to state Rep. Brandon Achor's campaign website. Act 624, introduced as House Bill 1150, was backed by the Arkansas Pharmacists Association and Attorney General Tim Griffin, and passed easily. Act 624 is scheduled to take effect January 1, 2026. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
3 hours ago
- Yahoo
Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer's Disease
TAINAN, June 12, 2025 /PRNewswire/ -- Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small molecule drug targeting early-stage Alzheimer's disease (AD). TML-6 combines multiple mechanisms, including anti-oxidative effects (Nrf2 activation), melioration of autophagy function (autolysosomal activation), anti-amyloid accumulation (β-amyloid clearance), and anti-inflammatory effects (through NF-κB inhibition) through autolysosome pathway in neurons and microglia to remove intraneuronal and extracellular amyloid accumulation, representing the first in human multi-target strategy for AD treatment. The Phase I trial showed excellent safety, tolerability, and pharmacokinetics at 100–200 mg in both healthy and elderly adults. TML-6 will now advance to a Phase II 19 site trial across the United States, Sweden, and Taiwan after FDA approval. This 12-month study will enroll 210 patients with mild cognitive impairment (MCI) or mild dementia. Primary endpoints will include neuropsychological assessments (CDR-SB, iADRS) and blood biomarkers (p-Tau 217, Aβ42/40, NfL, GFAP), supported by brain MRI, amyloid PET scans, and ApoE genotyping. Type C FDA consultation for phase 2 trial design has completed on 13 May 2025, with trial initiation expected in April 2026, conducted by Syneos Health CRO. With its strong preclinical and clinical profile, TML-6 holds promise as both a monotherapy and in combination with anti-amyloid biologics, providing new hope for patients with Alzheimer's disease. About Merry Life Biomedical Company Merry Life Biomedical is a Taiwan-based biotechnology company focused on developing innovative therapies for neurodegenerative and age-related diseases. Leveraging advanced molecular design, pharmacological innovation, formulation optimization and global clinical development, the company is committed to addressing urgent unmet medical needs. Media ContactDr. Ih-Jen SuMerry Life Biomedical Company, +886-910-902-296Email: suihjen0704@ View original content to download multimedia: SOURCE Merry Life Biomedical Company, Ltd. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNN
3 hours ago
- CNN
More than 290 feared dead after plane crashes outside airport in Indian city of Ahmedabad
At least 290 people are feared to have died after a plane bound for London crashed into a residential area shortly after taking off from an airport in India's western city of Ahmedabad. Images from the scene showed thick black smoke rising up into the sky after the Air India plane crashed, with part of the aircraft pictured resting on top of a building. Other images showed scorched trees and a fire-blackened building with first responders hosing down the area. Among those killed were passengers on the flight, including some minors, local residents, and people who were inside the BJ Medical College and Hospital hostel when the plane crashed into it, a senior doctor at the Ahmedabad Civil Hospital, where a majority of the dead and injured people were taken, told CNN. The doctor added that the death toll is likely to rise. Air India said that 242 people were on board the plane, 169 of them Indian nationals and 53 British nationals. There were also seven Portuguese nationals and one Canadian national, the airline added in a statement. It confirmed there had been a single survivor among those on board, a British national. The Hindustan Times named the survivor as a British national, Vishwash Kumar Ramesh, and said he was receiving treatment. What appears to be a copy of the flight manifest, shared by news agency IANS, lists Vishwash Kumar Ramesh as having been assigned seat 11A. The Hindustan Times said it spoke to Ramesh in a local hospital, and quoted him as saying: 'Thirty seconds after takeoff, there was a loud noise and then the plane crashed. It all happened so quickly.' A senior police officer told reporters that the plane had hit a doctors' hostel belonging to the BJ Medical College and Hospital. At least three medical students died, Swapnil Bhalodia of the Indian Medical Association Medical Students Network in Gujarat said. Between 50 and 60 medical students have been admitted to local hospitals, according to the Federation of All India Medical Association. The statement said two or three students are in intensive care. The flight, AI171, was bound for London's Gatwick Airport, where it was due to land at 6.25 p.m. local time (1.25 p.m. ET). A reception center has been set up at the airport to provide information and support to relatives of victims. One video captured the moment the aircraft, gaining altitude after just taking off, suddenly began to descend in mid air, before crashing down in a huge plume of fire and smoke. The plane made a Mayday call to Air Traffic Control shortly after takeoff, according to India's Directorate General of Civil Aviation (DGCA). 'But thereafter no response was given by the aircraft to the calls made by ATC. Aircraft immediately after departure from Runway 23, fell on ground outside the airport perimeter. Heavy black smoke was seen coming from the accident site,' the statement said. According to the DCGA statement, the flight departed at 1.39 p.m. local time (4.09 a.m. ET). The aircraft's signal was lost less than a minute after takeoff, at an altitude of 625 feet, according to FlightRadar24 data. The plane then started to descend with a vertical speed of -475 feet per minute, the data showed. All flights out of Ahmedabad's Sardar Vallabhbhai Patel International Airport were suspended following the incident. However, they have since resumed at a limited capacity, the airport said in a post on X. India's Prime Minister Narendra Modi said the plane crash had 'stunned and saddened' the country. He described the incident as 'heartbreaking beyond words,' adding that he was in touch with the authorities involved in the disaster. Natarajan Chandrasekaran, the chairman of Air India, said that Air India Flight AI171 had been involved in a 'tragic accident.' He added, 'We are doing everything in our power to assist the emergency response teams at the site and to provide all necessary support and care to those impacted.' Prev Next British Prime Minister Keir Starmer described the scenes as 'devastating,' and said he is 'being kept updated as the situation develops.' He added that his 'thoughts are with the passengers and their families at this deeply distressing time.' Meanwhile British Foreign Secretary David Lammy told the UK House of Commons: 'This morning, we know that British nationals were on board. And Mr. Speaker, I can confirm that the (Foreign, Commonwealth and Development Office) is working urgently with local authorities to support British nationals and their families, and has stood up a crisis team in both Delhi and in London.' The UK's King Charles said he and Queen Camilla are 'desperately shocked' by the 'terrible events' in Ahmedabad. He also paid tribute to the 'heroic efforts' of the emergency services and all those 'providing help and support at this most heartbreaking and traumatic time.' The UK and India have strong cultural and historic ties and a complicated history dating back to Britain's colonial era. The UK has a large Indian diaspora – according to data from the British government, in 2021, 1.9 million people or 3.1% of the country's population identified as having Indian ethnicity. Thursday's crash marks the first involving a Boeing 787 Dreamliner since the aircraft first entered into service in 2011, according to Boeing's Statistical Summary of Commercial Jet Airplane Accidents. According to Boeing, there are over 1,175 Dreamliners in service, which account for 2,100 flights each day. Boeing issued a statement in wake of the crash, saying it is in contact with Air India and stands 'ready to support them.' 'Our thoughts are with the passengers, crew, first responders and all affected,' it added in an X post. This is a developing story and will be updated. CNN's Olivia Kemp contributed to this report.
